Cell Harvesting Global Market Report 2024

The global cell harvesting market has grown strongly in recent years. It will grow from $10.07 billion in 2023 to $10.77 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth observed in the historical period can be attributed to several factors, including the increased prevalence of chronic diseases, higher investments in research and development, and the expanding applications of cell harvesting in regenerative medicine. These factors collectively contributed to the expansion witnessed during that timeframe.

The global cell harvesting market is expected to see strong growth in the next few years. It will grow to $14.09 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The anticipated growth in the forecast period can be attributed to various factors, including the increasing incidence of diseases, demographic trends such as an aging population, the broadening applications of cell harvesting in therapeutics, and strategic collaborations within the industry. Significant trends expected in the forecast period encompass technological advancements, ongoing product innovations, considerations related to the regulatory landscape, heightened market competition, and efforts towards global market expansion. These trends collectively contribute to the projected growth in the upcoming period.

The projected increase in chronic disease cases is poised to drive the growth of the cell harvesting market. Chronic diseases characterized by enduring health issues requiring continuous medical attention and impacting daily activities, necessitate ongoing research for innovative treatments. This heightened need for research leads to an increased demand for cell harvesting procedures in drug development. For example, research published by the American Cancer Society in January 2022 reveals that in the US, an anticipated 609,360 cancer deaths and 1.9 million new cancer cases in 2022 underline the urgency for cell harvesting procedures. This surge in chronic diseases, especially in the context of cancer, acts as a catalyst for the growth of the cell harvesting market.

The rising prevalence of cancer is expected to further propel the expansion of the cell harvesting market. As a group of diseases marked by uncontrolled cell growth forming tumors, cancer necessitates extensive research and diagnostic applications, driving the demand for cell harvesting. The American Cancer Society's January 2022 research highlights an anticipated 1.9 million new cancer cases in the US in 2022, emphasizing the critical role of cell harvesting in advancing cancer-related research, therapeutic development, and diagnostic applications. The increasing prevalence of cancer is a significant driver for the growth of the cell harvesting market.

Technological advancements emerge as a prominent trend in the cell harvesting market, with major players focusing on innovative technologies to maintain their market positions. In September 2022, Thermo Fisher Scientific Inc. introduced the DynaSpin Single-Use Centrifuge System, utilizing DynaSpin technology for extensive cell culture collection and centrifugation. This technology aids in achieving sustainability targets by significantly reducing material requirements and waste compared to conventional harvest systems. The emphasis on technological innovation contributes to the growth and competitiveness of the cell harvesting market.

Major companies operating in the cell harvesting market are investing in the development of sustainable solutions to expand their customer bases and increase revenue. Thermo Fisher Scientific Inc., in September 2022, launched the DynaSpin Centrifuge system as a sustainable solution for large-scale cell culture harvesting. This system not only enhances the cell culture separation process in single-use bioprocesses but also promotes operational efficiency and cost-effectiveness. Its sustainability features include a substantial reduction in material requirements and a 70% reduction in waste compared to traditional harvest systems. This focus on sustainability aligns with the broader trends in the life sciences industry and contributes to the growth of the cell harvesting market.

In a strategic move, Sartorius, a Germany-based life science company, acquired Xell AG in July 2021. This acquisition broadens Sartorius's product range, particularly in specialized media for viral vector production, and enhances its production network in the rapidly expanding sector. Xell AG, a cell culture specialist based in Germany, adds valuable expertise and capabilities to Sartorius's portfolio in the cell harvesting market.

Major companies operating in the cell harvesting market report are PerkinElmer Inc., Connectorate AG, Sartorius AG, Terumo Corporation, Cox Scientific Ltd., AVITA Medical Inc., Tomtec Inc., Teleflex Incorporated, Arthrex Inc., Antylia Scientific, Danaher Corporation, Bertin Technologies Group, Merck & Co. Inc., Eurofins Scientific SE, Agilent Technologies Inc., Pall Corporation, Thermo Fisher Scientific Inc., Scinomix Inc., Brandel Co., ADSTEC Corporation, Thomas Scientific Inc., Miltenyi Biotec Technology & Trading Co. Ltd., Terumo BCT Inc., Bertin Pharma SAS, GE Healthcare, Argos Technologies Inc., Esco Lifesciences Group, ReproCell Inc., and CESCO Bioengineering Co. Ltd.

North America was the largest region in the cell harvesting market share in 2023. The regions covered in the cell harvesting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell harvesting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of cell harvesting include manual cell harvesters and automated cell harvesters. Manual cell harvesters are medical devices used for collecting cells from a cell culture medium without the need for specialized instruments, involving the manual picking of cells. These manual cell harvesters find applications across various end-users, including biotechnology and biopharmaceutical companies, research institutes, and others. The distribution channels for these devices include retail and direct tenders.

This report provides cell harvesting market statistics, including the cell harvesting industry global market size, regional shares, competitors with a cell harvesting market share, detailed cell harvesting market segments, market trends and opportunities, and any further data you may need to thrive in the cell harvesting industry. This cell harvesting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell harvesting includes revenues earned by entities by centrifugation, filtration, and microfiltration. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.